419 related articles for article (PubMed ID: 17505938)
1. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
Berrevoets CA; Umar A; Trapman J; Brinkmann AO
Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay.
Xu LC; Sun H; Chen JF; Bian Q; Song L; Wang XR
Toxicol Lett; 2006 Jan; 160(2):151-7. PubMed ID: 16125883
[TBL] [Abstract][Full Text] [Related]
4. Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line.
Térouanne B; Paris F; Servant N; Georget V; Sultan C
Mol Cell Endocrinol; 2002 Dec; 198(1-2):143-7. PubMed ID: 12573824
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
6. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
[TBL] [Abstract][Full Text] [Related]
7. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
[TBL] [Abstract][Full Text] [Related]
9. Antiandrogens prevent stable DNA-binding of the androgen receptor.
Farla P; Hersmus R; Trapman J; Houtsmuller AB
J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
[TBL] [Abstract][Full Text] [Related]
10. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
[TBL] [Abstract][Full Text] [Related]
11. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
Guth SE; Böhm S; Mussler BH; Eisenbrand G
Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179
[TBL] [Abstract][Full Text] [Related]
12. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
[TBL] [Abstract][Full Text] [Related]
14. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
Chen F; Knecht K; Leu C; Rutledge SJ; Scafonas A; Gambone C; Vogel R; Zhang H; Kasparcova V; Bai C; Harada S; Schmidt A; Reszka A; Freedman L
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):247-57. PubMed ID: 15336702
[TBL] [Abstract][Full Text] [Related]
15. Molecular action of norgestimate: new developments.
Paris F; Balaguer P; Rimbault F; Gaspari L; Sultan C
Gynecol Endocrinol; 2015 Jun; 31(6):487-90. PubMed ID: 25970022
[TBL] [Abstract][Full Text] [Related]
16. Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens.
Avancès C; Georget V; Térouanne B; Orio F; Cussenot O; Mottet N; Costa P; Sultan C
Mol Cell Endocrinol; 2001 Nov; 184(1-2):13-24. PubMed ID: 11694337
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of androgen receptor transcriptional activities of some pesticides in vitro.
Xu LC; Liu L; Ren XM; Zhang MR; Cong N; Xu AQ; Shao JH
Toxicology; 2008 Jan; 243(1-2):59-65. PubMed ID: 17980950
[TBL] [Abstract][Full Text] [Related]
18. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S
Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
20. Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor.
Blankvoort BM; de Groene EM; van Meeteren-Kreikamp AP; Witkamp RF; Rodenburg RJ; Aarts JM
Anal Biochem; 2001 Nov; 298(1):93-102. PubMed ID: 11673900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
